PP-PFE-GBR-2272. January 2020

You must or to place an order.

Download and / or order the materials of your choice. There are no costs involved.

Select the quantity of the material you want to order and click 'Add to cart'

Alternatively click 'Download' to immediately download you selected material

When you have finished, click 'Place Order' within your cart

Filter search results

AMS Champions Guide

AMS Champions Guide

Guide for AMS Champions to implement an antimicrobial stewardship programme in their local clinical setting as directed by the programme lead. Please note this content is suggestive and not directive.

Ask Pfizer: If you would like to receive further information about these materials or our work to support AMS, please contact your local Pfizer Account Manager here.

PP-AIP-GBR-0269. January 2020

AMS Nurse leaflet

AMS Nurse leaflet

Educational poster/leaflet for Nurses to support them in their role in antimicrobial stewardship.

Ask Pfizer: If you would like to receive further information about these materials or our work to support AMS, please contact your local Pfizer Account Manager here.

PP-AIP-GBR-0268. January 2020

AMS Pharmacy Poster

AMS Pharmacy Poster

AMS poster to be put up in pharmacies / hospitals to educate patients on the issue of antimicrobial resistance.

Ask Pfizer: If you would like to receive further information about these materials or our work to support AMS, please contact your local Pfizer Account Manager here.

PP-AIP-GBR-0277. January 2020

Inlyta® (axitinib) Patient Treatment Information Brochure

This booklet is for patients prescribed Inlyta for advanced renal cell carcinoma (aRCC). It contains information about Inlyta, general advice on managing side effects, definition of relevant clinical terms as well as a diary and notes section. Click 'Download' to browse the content and if this is of interest,  please visit Medisa to request printed materials.

Click here for Prescribing and Adverse Event Reporting Information for Inlyta.  

PP-INL-GBR-0791. September 2020

SUTENT® (sunitinib malate) pNET Patient Treatment Diary

A diary to help patients with pancreatic neuroendocrine tumours (pNET) note appointments, questions, concerns and side effects related to their Sutent treatment. Click 'Download' to browse the content and if this is of interest,   please visit Medisa to request printed materials.

Click here for Prescribing and Adverse Event Reporting Information for Sutent.

PP-SUT-GBR-0640. September 2020

SUTENT® (sunitinib malate) ASSIST Carers' Information Brochure

This brochure offers guidance and support for people caring for patients prescribed Sutent for the treatment of advanced/metastatic renal cell carcinoma. Click 'Download' to browse the content and if this is of interest,  please visit Medisa to request printed materials.

Click here for Prescribing and Adverse Event Reporting Information for Sutent.  

PP-SUT-GBR-0644. September 2020

Inlyta® (axitinib) Blood Pressure Monitoring Booklet for Patients

This booklet helps patients prescribed Inlyta for advanced renal cell carcinoma (aRCC) understand blood pressure, how to measure it and provides a diary section to aid blood pressure tracking for 38 weeks. Click 'Download' to browse the content and if this is of interest,  please visit Medisa to request printed materials.

Click here for Prescribing and Adverse Event Reporting Information for Inlyta.  

PP-INL-GBR-0792. September 2020

SUTENT® (sunitinib malate) ASSIST Patient Treatment Diary

A diary to help patients with advanced/metastatic renal cell carcinoma note appointments, questions, concerns and side effects related to their Sutent treatment. Click 'Download' to browse the content and if this is of interest,  please visit Medisa to request printed materials.

Click here for Prescribing and Adverse Event Reporting Information for Sutent.

PP-SUT-GBR-0645. September 2020

SUTENT® (sunitinib malate) ASSIST Patient Treatment Booklet

This booklet offers guidance and support to patients prescribed Sutent for advanced/metastatic renal cell carcinoma. It helps them understand their condition, treatment and also includes tips to manage side effects. Click 'Download' to browse the content and if this is of interest,  please visit Medisa to request printed materials.

Click here for Prescribing and Adverse Event Reporting Information for Sutent.

PP-SUT-GBR-0643. September 2020

SUTENT® (sunitinib malate) pNET Patient Booklet

This booklet offers guidance and support to patients prescribed Sutent for pancreatic neuroendocrine tumours (pNET). It helps them understand their condition, treatment and also includes tips to manage side effects. Click 'Download' to browse the content and if this is of interest,  please visit Medisa to request printed materials.

Click here for Prescribing and Adverse Event Reporting Information for Sutent.

PP-SUT-GBR-0642. September 2020

SUTENT® (sunitinib malate) GIST Patient Brochure

This booklet offers guidance and support to patients prescribed Sutent for gastrointestinal stromal tumour (GIST). It helps them understand their condition, treatment and also includes tips to manage side effects. Click 'Download' to browse the content and if this is of interest,  please visit Medisa to request printed materials.

Click here for Prescribing and Adverse Event Reporting Information for Sutent.

PP-SUT-GBR-0641. September 2020

SUTENT® (sunitinib malate) GIST Patient Diary

A diary to help patients with gastrointestinal stromal tumour (GIST) note appointments, questions, concerns and side effects related to their Sutent treatment. Click 'Download' to browse the content and if this is of interest,  please visit Medisa to request printed materials.

Click here for Prescribing and Adverse Event Reporting Information for Sutent.

PP-SUT-GBR-0639. September 2020

SUTENT® (sunitinib malate) Treatment Tracker

A treatment tracker chart for patients on Sutent to help them remember to take their treatment as prescribed. Click 'Download' to browse the content and if this is of interest,  please visit Medisa to request printed materials.

Click here for Prescribing and Adverse Event Reporting Information for Sutent.

PP-SUT-GBR-0638. September 2020